Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The instruments are valid but don't fully capture the emotional impact on adolescents with alopecia areata.

Alopecia totalis/universalis is linked to more autoimmune diseases than patchy alopecia areata.

Frontal fibrosing alopecia is linked to thyroid disease, lupus, vitiligo, and heart disease.

Certain skin and family history markers predict vitiligo severity and treatment needs.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Skin infections and rashes are the most common skin problems in children.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Organoids and organ chips can improve eye disease research and treatment.

Hair loss from cancer treatment is a major emotional burden for patients because it affects their appearance and constantly reminds them of their illness.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Alopecia areata severity and child's age greatly affect the quality of life for children and their parents.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Severe scars need a mix of treatments for best results.

Alopecia areata significantly affects emotional well-being and daily activities, suggesting a need for patient-centered care.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Alopecia areata patients face significant mental distress, but psychological support is lacking.

The new tool helps measure the impact of alopecia areata on children's quality of life.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.